Twist Bioscience Corp. (TWST)
138.72
+5.97
(+4.50%)
USD |
NASDAQ |
Oct 19, 14:02
Twist Bioscience Cash from Operations (Annual) : -47.63M for Sept. 30, 2025
Cash from Operations (Annual) Chart
Historical Cash from Operations (Annual) Data
| Date | Value |
|---|---|
| September 30, 2025 | -47.63M |
| September 30, 2024 | -64.09M |
| September 30, 2023 | -142.47M |
| September 30, 2022 | -124.38M |
| September 30, 2021 | -112.24M |
| Date | Value |
|---|---|
| September 30, 2020 | -142.26M |
| September 30, 2019 | -87.94M |
| September 30, 2018 | -66.16M |
| September 30, 2017 | -51.30M |
| September 30, 2016 | -38.59M |
Cash From Operations Definition
Represents the net cash flow from the company's business operations.
Cash from Operations (Annual) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Cash from Operations (Annual) Benchmarks
| Intellia Therapeutics, Inc. | -394.74M |
| Beam Therapeutics, Inc. | -345.10M |
| Prime Medicine, Inc. | -162.56M |
| Absci Corp. | -92.92M |
| 10X Genomics, Inc. | 136.05M |